SynthesisBMC cancer2025
Impact of cardiovascular disease on colorectal cancer morbidity and prognosis.
Synthesis in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundColorectal cancer (CRC) and cardiovascular disease (CVD) are major global health burdens, sharing common risk factors like obesity, smoking, and diabetes. While CRC's impact on CVD has been studied, the reverse association remains less explored. The study aims to investigate the relationship between CVD and the morbidity and prognosis of CRC. MATERIALS: This study was conducted across 9 databases (PubMed, Embase, Cochrane, Scopus, Web of Science, CINAHL complete, SPORT Discus, PsycINFO and CNKI) from January 1, 2000, to February 27, 2025. The prognosis were diagnosis of colorectal cancer or postoperative prognosis (including death and complications). This study was analyzed by Stata (V. 16.0) software.
resultsA total of 23 studies were included: 11 studies (5,462,791 patients) from 6 countries or regions assessed morbidity risk, and 12 studies (307,857 patients) from 9 countries evaluated postoperative prognosis. Cardiovascular disease (CVD) was associated with increased risks for colorectal cancer (CRC) (RR 1.24, 95%CI 1.04 to 1.48) (CI, confidence intervals) (RR, relative risk), postoperative arrhythmia (RR 3.05, 95%CI 1.27 to 7.35), and all-cause mortality (RR 1.56, 95%CI 1.26 to 1.94). Subgroup analysis shows that heart failure (HF) may be a risk factor for CRC (RR 1.39, 95%CI 1.03 to 1.89) and all-cause mortality (RR 1.68, 95%CI 1.49 to 1.90). Among female patients, HF (RR 2.32, 95%CI 1.39 to 3.88) and heart failure with preserved ejection fraction (HFpEF) (RR 2.54, 95%CI 1.52 to 4.24) show associations with CRC.
conclusionsCVD was associated with increased risks of CRC incidence and all-cause mortality in CRC patients, with HF specifically linked to both outcomes. However, no conclusive associations emerged between CVD and postoperative complications beyond arrhythmia. Further investigation into physiological mechanism is required. PROSPERO ID: : CRD420251020352.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.